New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 21, 2014
08:02 EDTERBERBA Diagnostics receives 510(K) clearance for XL200 analyzer
ERBA Diagnostics announced that it has received clearance from the U.S. Food and Drug Administration on the 510(k) premarket submission that ERBA Diagnostics had filed for its new clinical chemistry analyzer the XL 200. The XL-200 is a state-of-the-art, random access, clinical chemistry analyzer that can perform up to 400 tests per hour.
News For ERB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 27, 2016
08:14 EDTERBERBA Diagnostics' compliance plan accepted by NYSE MKT
ERBA Diagnostics announced that the company received a letter from NYSE MKT LLC stating that the Exchange has accepted the company's plan of compliance for continued listing relating to the company's failure to timely file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2015. The company was afforded the opportunity to submit a plan of compliance to the Exchange and, on December 10, 2015, the company presented its Plan to the Exchange. On January 22, 2016, the Exchange notified the company that it accepted the company's Plan and granted the company an extension until May 25, 2016 to regain compliance with the continued listing standards of the company guide. The company will be subject to periodic review by the Exchange during the Plan Period. Failure to make progress consistent with the Plan or to regain compliance with the continued listing standards of the company Guide by the end of the Plan Period could result in the Company being delisted from the Exchange. The company is working diligently to regain compliance with the company guide by May 25, 2016.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use